Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
249.4 CHF | -0.38% | -1.23% | +2.13% |
02:10pm | Roche's Eye Therapy Vabysmo Gets EU Panel's Nod for Additional Indication | MT |
02:04pm | Roche: positive CHMP opinion for Vabysmo in OVR | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.13% | 225B | |
+56.64% | 819B | |
-6.65% | 351B | |
+19.15% | 329B | |
+9.41% | 298B | |
+16.79% | 242B | |
+13.20% | 217B | |
+8.97% | 168B | |
-2.87% | 158B | |
+0.20% | 120B |
- Stock Market
- Equities
- ROG Stock
- News Roche Holding AG
- Roche Wins EU Nod for Subcutaneous Formula of Multiple Sclerosis Drug Ocrevus